Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:581 (22 September), doi:10.1136/bmj.39339.361181.DB
Susan Mayor
London
| The first 150 words of the full text of this article appear below. |
Women will be reimbursed about half the cost of their in vitro fertilisation in return for donating "surplus" eggs for stem cell research, in the first study funded by the UK Medical Research Council (MRC) that will pay participants.
The MRC announced last week that it is funding a research proposal from the North East England Stem Cell Institute (NESCI), based in Newcastle, to find ways of improving the efficiency of therapeutic cloning. This technique is designed to create stem cells specific to a patient that might eventually be used to treat conditions in which new cells could be therapeutic—such as diabetes, heart disease, and Parkinson's disease.
Out of the funding of £470 000 (
680 000; $950 000) for the research, the MRC will provide £150 000 to reimburse part of the cost of treatment for women undergoing in vitro fertilisation at the Newcastle Fertility Centre and who donate
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?